Principal, Application and Services
Inventia Life Science, Australia
Dr Martin Engel is the Principal, Application and Services at Inventia Life Science, guiding the development of novel 3D cell cultures and organoid models on the RASTRUM platform. Dr Engel joint Inventia with extensive experience in developing and using preclinical models, including stem-cell derived organoids and 3D tissue cultures, from his previous work at the University of Wollongong, and NeuroSearch A/S. He holds a PhD in Neuroscience from the University of Wollongong, and interacts widely with the Australian and international biomedical community to continue aiding preclinical discoveries.